Decreased blood riboflavin levels are correlated with defective expression ofRFT2gene in gastric cancer
Author:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (24) , 3112-8
Abstract
To investigate the relationship between blood riboflavin levels and riboflavin transporter 2 (RFT2) gene expression in gastric carcinoma (GC) development. High-performance liquid chromatography was used to detect blood riboflavin levels in patients with GC. Real-time fluorogenic quantitative polymerase chain reaction and immunohistochemistry were used to analyze the expression of RFT2 mRNA and protein in samples from 60 GC patients consisting of both tumor and normal tissue. A significant decrease in the RFT2 mRNA levels was detected in GC samples compared with those in the normal mucous membrane (0.398 ± 0.149 vs 1.479 ± 0.587; P = 0.040). Tumors exhibited low RFT2 protein expression (75%, 16.7%, 8.3% and 0% for no RFT2 staining, weak staining, medium staining and strong staining, respectively), which was significantly lower than that in the normal mucous membrane (10%, 16.7%, 26.7% and 46.7% for no RFT2 staining, weak staining, medium staining and strong staining, respectively; P < 0.05). Tumors with low RFT2 expression were significantly associated with tumor stage and histological grade. Moreover, a significantly decrease in Uyghur patients was observed compared with Han patients. However, other parameters-gender, tumor location and lymph node metastasis-showed no significant relationship with RFT2 expression. Blood riboflavin levels were reverse correlated with development of GC (1.2000 ± 0.97569 ng/mL in high tumor stage patients vs 2.5980 ± 1.31129 ng/mL in low tumor stage patients; P < 0.05). A positive correlation of plasma riboflavin levels with defective expression of RFT2 protein was found in GC patients (χ² = 2.619; P = 0.019). Defective expression of RFT2 is associated with the development of GC and this may represent a mechanism underlying the decreased plasma riboflavin levels in GC.Keywords
This publication has 24 references indexed in Scilit:
- Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinomaWorld Journal of Gastroenterology, 2011
- Rapid determination of vitamin B2 (riboflavin) in plasma by HPLCClinica Chimica Acta, 2011
- Emerging Roles for Riboflavin in Functional Rescue of Mitochondrial β-Oxidation FlavoenzymesCurrent Medicinal Chemistry, 2010
- Functional Characteristics of the Human Ortholog of Riboflavin Transporter 2 and Riboflavin-Responsive Expression of Its Rat Ortholog in the Small Intestine Indicate Its Involvement in Riboflavin Absorption , ,The Journal of Nutrition, 2010
- Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1Nature Genetics, 2010
- Brown-Vialetto-Van Laere Syndrome, a Ponto-Bulbar Palsy with Deafness, Is Caused by Mutations in C20orf54The American Journal of Human Genetics, 2010
- The global burden of cancer: priorities for preventionCarcinogenesis, 2009
- Identification and Functional Characterization of Rat Riboflavin Transporter 2The Journal of Biochemistry, 2009
- Nutrient intake and risk of subtypes of esophageal and gastric cancer.2001
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001